REG - Kainos Group plc - Total Voting Rights

KainosAnnouncement

06/01/2020 09:45

RNS Number : 8287Y
Kainos Group plc
06 January 2020
 


6 January 2020
Kainos Group plc
("Kainos" or the "Company") 
Total Voting Rights
Pursuant to DTR 5.6.1 the Company announces that as at 6 January 2020, the total number of ordinary shares in issue now stands at 121,874,596 each with voting rights. There are no shares held in treasury.
 
The above figure (121,874,596) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.
 
Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47 
Classification: 2.5 - Total number of voting rights and capital
 
Ends
 
For further information, please contact:
 
Kainos                                                                                         via FTI Consulting LLP
Brendan Mooney, Chief Executive Officer
Richard McCann, Chief Financial Officer
 
Investec Bank plc                                                                               +44 20 7597 5970
Patrick Robb / Sebastian Lawrence
 
Canaccord Genuity Limited                                                               +44 20 7523 4606
Simon Bridges/ Andrew Potts
 
FTI Consulting LLP                                                                            +44 20 3727 1000
Matt Dixon / Kwaku Aning / Leah Dudley
 
About Kainos
Kainos Group plc is a UK-headquartered provider of Digital Services and Digital Platforms.
The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday, Inc. ('Workday'), responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.
The Group's Digital Platforms comprise specialised digital platforms in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market-leading product for the digitisation of patient notes in the Acute sector of the NHS.
Kainos has over 1,550 people across 12 offices in Europe and North America.
Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com.  





This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TVRKQLBBBFLZBBB